News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Intralytix Signs Multiple Project Collaboration Agreement With Procter & Gamble (PG)


9/22/2011 9:25:43 AM

BALTIMORE--(BUSINESS WIRE)--Intralytix, Inc., announced today that it has entered into a Multiple Project Collaboration Agreement (“MPCA”) with The Procter & Gamble Company (NYSE:PG). “The MPCA sets the stage for Intralytix and P&G to collaborate on the development of bacteriophage (or phage) based technology for a range of applications,” stated John Woloszyn, Intralytix’s CEO. “Our phage-based technology is all natural and environmentally friendly and we look forward to this collaboration bringing forth new innovations,” Mr. Woloszyn added.

Read at BioSpace.com


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES